DGAP Voting Rights Announcement: Heidelberg Pharma AG
Heidelberg Pharma AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27.11.2017 / 14:00
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Heidelberg Pharma AG
Schriesheimer Str. 101
68526 Ladenburg
Germany

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
X Change of breakdown of voting rights
X Other reason:
voluntary group disclosure relating to exceeding threshold at a subsidiaries level

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Mr Dietmar Hopp,
Date of birth: 26 Apr 1940

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
dievini Hopp BioTech holding GmbH & Co. KG, DH-Holding Verwaltungs GmbH

5. Date on which threshold was crossed or reached:
22 Nov 2017

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 total of both in %
(7.a. + 7.b.)		 total number of voting rights of issuer
Resulting situation 70.26 % 0.00 % 70.26 % 22452570
Previous notification 66.96 % 0.00 % 66.96 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in %
  direct
(Sec. 21 WpHG)		 indirect
(Sec. 22 WpHG)		 direct
(Sec. 21 WpHG)		 indirect
(Sec. 22 WpHG)
DE000A11QVV0 171538 15604389 0.76 % 69.50 %
Total 15775927 70.26 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
   Total %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
     Total %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Zurechnungsstrang 1 - attribution of shares 1 % % %
Herr Dietmar Hopp - % - % - %
DH-Holding GmbH & Co. KG - % - % - %
DH-Holding Verwaltungs GmbH 4.17 % - % - %
Zurechnungsstrang 2 - attribution of shares 2 % % %
Herr Dietmar Hopp - % - % - %
Hopp LT Vermögensverwaltung GmbH - % - % - %
DH-Capital GmbH & Co. KG - % - % - %
dievini Hopp BioTech holding GmbH & Co. KG 65.33 % - % 65.33 %
Zurechnungsstrang 3 - attribution of shares 3 % % %
Herr Dietmar Hopp - % - % - %
DH Verwaltungs GmbH - % - % - %
DH-Capital GmbH & Co. KG - % - % - %
dievini Hopp BioTech holding GmbH & Co. KG 65.33 % - % 65.33 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
 


27.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Heidelberg Pharma AG
Schriesheimer Str. 101
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News DGAP News Service

632991  27.11.2017 

fncls.ssp?fn=show_t_gif&application_id=632991&application_name=news&site_id=zonebourse